SWOG clinical trial number
S1400 VCP
S1400 Version Control Protocol
Closed
Abbreviated Title
S1400 Version Control Protocol
Status Notes
The purpose of this memorandum is to notify sites that the new administrative protocol S1400VCP (Version Control Protocol) is now available on the S1400 Abstract Page Links on the SWOG website (http://swog.org).
The intent of the S1400VCP is to allow an individual sub-study to be revised independently of the other sub-studies. The S1400VCP keeps track of revisions or updates made to the various sub-studies and their component documents over the course of the overarching Lung-MAP study, and lists the version date of each component of Lung-MAP associated with each revision or update.
Sites may use this document to verify the most current version of a sub-study, and may also reference this document for an overview of Lung-MAP revisions.
The intent of the S1400VCP is to allow an individual sub-study to be revised independently of the other sub-studies. The S1400VCP keeps track of revisions or updates made to the various sub-studies and their component documents over the course of the overarching Lung-MAP study, and lists the version date of each component of Lung-MAP associated with each revision or update.
Sites may use this document to verify the most current version of a sub-study, and may also reference this document for an overview of Lung-MAP revisions.
Activated
09/22/2017
Closed
02/15/2022
Research committees
Lung Cancer
Other Clinical Trials
SWOG Clinical Trial Number
S2302
PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
95%
Open
Phase
SWOG Clinical Trial Number
A082002
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007
RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open